MUSTANG BIO, INC.

Related Filers (16)

Financials (30)

10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Friday, 5/12/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 3/30/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 11/14/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Wednesday, 3/23/2022
Annual Report for period ending 2021-12-31
10-Q
Friday, 11/12/2021
Quarterly Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Friday, 5/14/2021
Quarterly Report for period ending 2021-03-31
10-K
Wednesday, 3/24/2021
Annual Report for period ending 2020-12-31
10-Q
Friday, 11/6/2020
Quarterly Report for period ending 2020-09-30
10-Q
Monday, 8/10/2020
Quarterly Report for period ending 2020-06-30
10-Q
Monday, 5/11/2020
Quarterly Report for period ending 2020-03-31
10-K
Monday, 3/16/2020
Annual Report for period ending 2019-12-31
10-Q
Tuesday, 11/12/2019
Quarterly Report for period ending 2019-09-30
10-Q
Friday, 8/9/2019
Quarterly Report for period ending 2019-06-30
10-Q
Friday, 5/10/2019
Quarterly Report for period ending 2019-03-31
10-K
Monday, 3/18/2019
Annual Report for period ending 2018-12-31
10-Q
Tuesday, 11/13/2018
Quarterly Report for period ending 2018-09-30
10-Q
Monday, 8/13/2018
Quarterly Report for period ending 2018-06-30
10-Q
Monday, 5/14/2018
Quarterly Report for period ending 2018-03-31
10-K
Thursday, 3/29/2018
Annual Report for period ending 2017-12-31
10-Q
Tuesday, 11/14/2017
Quarterly Report for period ending 2017-09-30
10-Q/A
Tuesday, 11/14/2017
Quarterly Report for period ending 2017-06-30
10-Q
Monday, 8/14/2017
Quarterly Report for period ending 2017-06-30
10-Q
Monday, 5/15/2017
Quarterly Report for period ending 2017-03-31
10-K
Friday, 3/31/2017
Annual Report for period ending 2016-12-31
10-Q
Monday, 11/14/2016
Quarterly Report for period ending 2016-09-30
Show More

News (86)

8-K
Wednesday, 2/14/2024
Current report filing
8-K
Thursday, 1/25/2024
Current report filing
8-K
Thursday, 1/4/2024
Current report filing
8-K
Tuesday, 12/12/2023
Current report filing
8-K
Monday, 12/11/2023
Current report filing
8-K
Tuesday, 11/14/2023
Current report filing
8-K
Thursday, 11/2/2023
Current report filing
8-K
Monday, 10/30/2023
Current report filing
8-K
Thursday, 10/26/2023
Current report filing
8-K
Wednesday, 10/4/2023
Current report filing
8-K
Wednesday, 8/16/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Monday, 7/31/2023
Current report filing
8-K
Thursday, 7/20/2023
Current report filing
8-K
Tuesday, 7/11/2023
Current report filing
8-K
Friday, 6/30/2023
Current report filing
8-K
Friday, 6/23/2023
Current report filing
8-K
Monday, 5/22/2023
Current report filing
8-K
Friday, 5/12/2023
Current report filing
8-K
Thursday, 4/20/2023
Current report filing
8-K
Thursday, 4/13/2023
Current report filing
8-K
Monday, 4/3/2023
Current report filing
8-K
Wednesday, 3/29/2023
Current report filing
8-K
Friday, 3/3/2023
Current report filing
8-K
Tuesday, 12/13/2022
Current report filing
8-K
Friday, 11/25/2022
Current report filing
8-K
Monday, 11/14/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Thursday, 7/7/2022
Current report filing
8-K
Friday, 6/24/2022
Current report filing
8-K
Tuesday, 5/31/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Friday, 4/22/2022
Current report filing
8-K
Wednesday, 3/23/2022
Current report filing
8-K
Thursday, 3/17/2022
Current report filing
8-K
Tuesday, 3/8/2022
Current report filing
8-K
Friday, 11/12/2021
Current report filing
8-K
Tuesday, 9/28/2021
Current report filing
8-K
Friday, 9/24/2021
Current report filing
8-K
Monday, 8/16/2021
Current report filing
8-K
Tuesday, 6/22/2021
Current report filing
8-K
Friday, 5/14/2021
Current report filing
8-K
Wednesday, 3/24/2021
Current report filing
8-K
Thursday, 12/31/2020
Current report filing
8-K
Friday, 12/4/2020
Current report filing
8-K
Friday, 11/6/2020
Current report filing
8-K
Monday, 10/5/2020
Current report filing
8-K
Monday, 8/10/2020
Current report filing
8-K
Friday, 7/24/2020
Current report filing
8-K
Friday, 6/19/2020
Current report filing
8-K
Monday, 6/15/2020
Current report filing
8-K
Monday, 5/11/2020
Current report filing
8-K
Monday, 3/16/2020
Current report filing
8-K
Tuesday, 11/12/2019
Current report filing
8-K
Monday, 9/30/2019
Current report filing
8-K
Friday, 8/9/2019
Current report filing
8-K
Wednesday, 6/19/2019
Current report filing
8-K
Friday, 5/10/2019
Current report filing
8-K
Tuesday, 4/30/2019
Current report filing
8-K
Thursday, 4/4/2019
Current report filing
8-K
Monday, 3/18/2019
Current report filing
8-K
Wednesday, 11/14/2018
Current report filing
8-K
Monday, 8/13/2018
Current report filing
8-K
Friday, 7/27/2018
Current report filing
8-K
Friday, 6/15/2018
Current report filing
8-K
Tuesday, 5/15/2018
Current report filing
8-K
Thursday, 3/29/2018
Current report filing
8-K
Tuesday, 11/14/2017
Current report filing
8-K
Monday, 10/30/2017
Current report filing
8-K
Monday, 8/14/2017
Current report filing
8-K
Tuesday, 6/13/2017
Current report filing
8-K
Friday, 6/9/2017
Current report filing
8-K
Tuesday, 6/6/2017
Current report filing
8-K
Monday, 4/24/2017
Current report filing
8-K
Thursday, 3/23/2017
Current report filing
8-K
Friday, 2/24/2017
Current report filing
8-K
Monday, 2/6/2017
Current report filing
8-K
Friday, 1/6/2017
Current report filing
8-K
Tuesday, 1/3/2017
Current report filing
8-K
Friday, 12/16/2016
Current report filing
8-K
Tuesday, 12/6/2016
Current report filing
8-K
Monday, 10/31/2016
Current report filing
8-K
Tuesday, 10/25/2016
Current report filing
8-K
Thursday, 10/20/2016
Current report filing
8-K
Thursday, 10/6/2016
Current report filing
8-K
Wednesday, 10/5/2016
Current report filing
Show More

Other (33)

D
Friday, 11/3/2023
Exempt (Private) Offering
CORRESP
Monday, 8/28/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
PX14A6G
Tuesday, 6/15/2021
Notice of exempt solicitation
EFFECT
Monday, 5/24/2021
Notice of Effectiveness
CORRESP
Thursday, 5/20/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 12/4/2020
Notice of Effectiveness
CORRESP
Wednesday, 12/2/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
PX14A6G
Friday, 5/29/2020
Notice of exempt solicitation
EFFECT
Monday, 9/30/2019
Notice of Effectiveness
CORRESP
Thursday, 9/26/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 8/30/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 7/27/2018
Notice of Effectiveness
CORRESP
Tuesday, 7/24/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 7/20/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Monday, 11/20/2017
Order Granting Confidential Treatment
CT ORDER
Wednesday, 9/27/2017
Order Granting Confidential Treatment
8-A12B
Monday, 8/21/2017
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERTNAS
Monday, 8/21/2017
None
D
Wednesday, 4/12/2017
Exempt (Private) Offering
D/A
Wednesday, 2/15/2017
Exempt (Private) Offering
D/A
Friday, 1/13/2017
Exempt (Private) Offering
D/A
Friday, 1/13/2017
Exempt (Private) Offering
D/A
Tuesday, 12/13/2016
Exempt (Private) Offering
D/A
Friday, 11/4/2016
Exempt (Private) Offering
CT ORDER
Monday, 10/24/2016
Order Granting Confidential Treatment
10-12G/A
Tuesday, 10/18/2016
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Tuesday, 10/18/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Monday, 10/17/2016
Exempt (Private) Offering
10-12G/A
Friday, 10/7/2016
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Friday, 10/7/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G/A
Thursday, 9/15/2016
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Thursday, 9/15/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G
Thursday, 7/28/2016
Initial general form for registration of a class of securities pursuant to Section 12(g)
Show More

Ownership (81)

SC 13G
Wednesday, 2/14/2024
ARMISTICE CAPITAL, LLC: Major Shareholders
3
Monday, 2/12/2024
MURPHY JAMES B: Initial statement of beneficial ownership of securities
4
Wednesday, 1/3/2024
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/19/2023
Carney Peter: Initial statement of beneficial ownership of securities
4
Friday, 7/7/2023
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
ZELEFSKY MICHAEL J: Statement of changes in beneficial ownership of securities
3/A
Thursday, 4/6/2023
WEISS MICHAEL S: Initial statement of beneficial ownership of securities
3/A
Thursday, 4/6/2023
ROSENWALD LINDSAY A MD: Initial statement of beneficial ownership of securities
4
Monday, 4/3/2023
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
ZELEFSKY MICHAEL J: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 1/13/2023
Fortress Biotech, Inc.: Major Shareholders
4
Friday, 1/6/2023
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 7/8/2022
BlackRock Inc.: Major Shareholders
3
Tuesday, 6/7/2022
Lurier Eliot M: Initial statement of beneficial ownership of securities
SC 13G
Friday, 2/4/2022
BlackRock Inc.: Major Shareholders
4
Thursday, 12/16/2021
Achenbach Brian: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Thursday, 10/21/2021
Achenbach Brian: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 9/24/2021
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Thursday, 8/5/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
ZELEFSKY MICHAEL J: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Thursday, 4/29/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 4/16/2021
Achenbach Brian: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 4/12/2021
BlackRock Inc.: Major Shareholders
4
Monday, 3/15/2021
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Monday, 3/15/2021
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Monday, 3/15/2021
Achenbach Brian: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/2/2021
BlackRock Inc.: Major Shareholders
4
Tuesday, 12/22/2020
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 12/22/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 12/22/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
ZELEFSKY MICHAEL J: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/19/2020
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/29/2020
ZELEFSKY MICHAEL J: Initial statement of beneficial ownership of securities
4
Wednesday, 4/29/2020
Achenbach Brian: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/29/2020
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
Achenbach Brian: Statement of changes in beneficial ownership of securities
4/A
Friday, 1/17/2020
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
4
Friday, 1/17/2020
Herskowitz Neil: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 5/17/2019
Fortress Biotech, Inc.: Major Shareholders
4
Tuesday, 12/18/2018
Litchman Manuel MD: Statement of changes in beneficial ownership of securities
4
Friday, 12/7/2018
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 12/3/2018
Achenbach Brian: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/27/2018
Achenbach Brian: Initial statement of beneficial ownership of securities
4
Tuesday, 11/13/2018
Chill Adam J.: Statement of changes in beneficial ownership of securities
4
Monday, 11/5/2018
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
3/A
Thursday, 7/20/2017
WEISS MICHAEL S: Initial statement of beneficial ownership of securities
3/A
Thursday, 7/20/2017
Chill Adam J.: Initial statement of beneficial ownership of securities
3
Thursday, 7/20/2017
ROSENWALD LINDSAY A MD: Initial statement of beneficial ownership of securities
3
Friday, 6/30/2017
Herskowitz Neil: Initial statement of beneficial ownership of securities
3
Friday, 6/30/2017
WEISS MICHAEL S: Initial statement of beneficial ownership of securities
3
Friday, 6/30/2017
Litchman Manuel MD: Initial statement of beneficial ownership of securities
3
Friday, 6/30/2017
Horin David J: Initial statement of beneficial ownership of securities
3
Friday, 6/30/2017
Chill Adam J.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/7/2017
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/7/2017
Fortress Biotech, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 5/26/2017
Fortress Biotech, Inc.: Major Shareholders
SC 13G
Tuesday, 2/14/2017
City of Hope: Major Shareholders
Show More

Prospectus (23)

S-1
Tuesday, 12/12/2023
General form of registration statement for all companies including face-amount certificate companies
424B5
Monday, 10/30/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 8/1/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 4/14/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Friday, 7/15/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Friday, 7/30/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Friday, 7/30/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3/A
Thursday, 5/20/2021
Registration statement for specified transactions by certain issuers
S-3
Friday, 4/23/2021
Registration statement for specified transactions by certain issuers
S-8
Friday, 4/2/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Thursday, 12/31/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 12/4/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Friday, 10/23/2020
Registration statement for specified transactions by certain issuers
424B5
Monday, 7/20/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 6/12/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 6/10/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Friday, 8/16/2019
Registration statement for specified transactions by certain issuers
424B5
Wednesday, 5/1/2019
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 4/29/2019
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 7/27/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Friday, 7/20/2018
Registration statement for specified transactions by certain issuers
S-3
Friday, 7/13/2018
Registration statement for specified transactions by certain issuers
S-8
Thursday, 11/30/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Show More

Proxies (24)

DEF 14A
Friday, 4/28/2023
Definitive proxy statements
DEFA14A
Friday, 4/28/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14C
Monday, 3/13/2023
Definitive information statements
PRE 14C
Friday, 3/3/2023
Preliminary information statement not related to a contested matter or merger/acquisition
DEFA14A
Friday, 4/29/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/29/2022
Definitive proxy statements
PRE 14A
Tuesday, 4/19/2022
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Friday, 4/30/2021
Definitive proxy statements
DEFA14A
Friday, 4/30/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Tuesday, 4/20/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14C
Friday, 11/13/2020
Definitive information statements
PRE 14C
Friday, 10/23/2020
Preliminary information statement not related to a contested matter or merger/acquisition
DEFA14A
Thursday, 6/4/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 4/29/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/29/2020
Definitive proxy statements
DEF 14C
Tuesday, 9/10/2019
Definitive information statements
PRER14C
Friday, 8/30/2019
Preliminary revised information statements
PRE 14C
Friday, 8/16/2019
Preliminary information statement not related to a contested matter or merger/acquisition
DEFA14A
Tuesday, 4/30/2019
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Tuesday, 4/30/2019
Definitive proxy statements
DEF 14A
Monday, 4/30/2018
Definitive proxy statements
DEFA14A
Monday, 4/30/2018
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Friday, 4/20/2018
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Friday, 4/28/2017
Definitive proxy statements
Show More